Indies Pharma Jamaica Limited (JMSE:INDIES)

Jamaica flag Jamaica · Delayed Price · Currency is JMD
2.870
+0.020 (0.70%)
At close: Dec 4, 2025
-10.03%
Market Cap 3.82B
Revenue (ttm) 1.15B
Net Income (ttm) 244.56M
Shares Out 1.33B
EPS (ttm) 0.18
PE Ratio 15.69
Forward PE n/a
Dividend 0.11 (3.86%)
Ex-Dividend Date Mar 31, 2025
Volume 97,150
Average Volume 33,017
Open n/a
Previous Close 2.850
Day's Range 2.850 - 2.870
52-Week Range 2.660 - 4.180
Beta 0.11
RSI 46.02
Earnings Date Dec 12, 2025

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2003
Employees 65
Stock Exchange Jamaica Stock Exchange
Ticker Symbol INDIES
Full Company Profile

Financial Performance

In 2024, Indies Pharma Jamaica's revenue was 1.16 billion, an increase of 9.81% compared to the previous year's 1.06 billion. Earnings were 251.77 million, an increase of 15.69%.

Financial Statements

News

There is no news available yet.